Myocardial infarction (MI) is irreversible necrosis of cardiac muscle tissue resulting from acute coronary artery occlusion, typically due to thrombotic occlusion at the site of a ruptured atherosclerotic plaque. Cardiac myocytes die within 20-40 minutes of complete ischemia, triggering a biphasic inflammatory response: an initial neutrophil-macrophage infiltration for debris clearance, followed by a resolution phase involving angiogenesis, fibroblast activation, and scar formation. The balance between necessary healing inflammation and pathological inflammation determines outcomes including heart failure, arrhythmias, and mortality.
Imagine a city where a water main has burst, flooding a neighborhood. The initial damage happens fast—within 20-40 minutes, every building downstream of the break loses water pressure and starts to fail. The structural collapse releases alarms (DAMPs) that summon emergency crews. First responders (neutrophils) arrive within hours, bulldozing debris and clearing rubble. Within days, specialized construction crews (macrophages) arrive to haul away the wreckage and coordinate rebuilding. Meanwhile, protective scaffolding (complement C3) props up buildings that are still standing but damaged, preventing further collapse.
But here's the catch: if the emergency response is too aggressive, the crews start demolishing buildings that could have been saved (reperfusion injury). The construction phase brings in cement mixers (fibroblasts) that pour a concrete foundation (collagen scar) where the old neighborhood stood—it's stable and prevents total structural failure, but it's rigid and can never function like the original buildings. The quality of the final repair depends on whether the cleanup crews arrive on time, work efficiently, and know when to stop. Meanwhile, the entire city's plumbing system (coronary arteries) remains vulnerable to future breaks at other weak points.
Initiation Phase:
Atherosclerotic plaque rupture exposes subendothelial collagen, tissue factor, and von Willebrand factor to circulating blood → platelet adhesion via GPIb-V-IX receptor binding to von Willebrand factor → platelet activation and release of ADP, thromboxane A2, and serotonin → recruitment of additional platelets via GPIIb/IIIa receptor-fibrinogen binding → thrombus formation
Tissue factor exposure → Factor VII activation → extrinsic coagulation cascade → thrombin generation → fibrin deposition stabilizing the platelet plug → complete coronary artery occlusion
Ischemic Injury Cascade:
Oxygen deprivation → ATP depletion via impaired oxidative phosphorylation → Na⁺-K⁺ ATPase failure → intracellular Na⁺ accumulation and K⁺ loss → cellular edema → Ca²⁺ overload via failed Na⁺-Ca²⁺ exchanger → activation of calcium-dependent proteases and phospholipases → sarcolemmal disruption → myocyte death within 20-40 minutes
Inflammatory Phase (Hours to Days):
Necrotic cardiomyocytes release DAMPs (HMGB1, cardiac troponins I and T, heat shock proteins, mitochondrial DNA, ATP) → activation of TLR2, TLR4, and NLRP3 inflammasome in resident cardiac macrophages and dendritic cells → NF-κB activation → production of IL-1β, IL-6, TNF-α, and chemokines (CXCL1, CXCL2, CCL2)
CCL2 (MCP-1) production → recruitment of circulating monocytes and neutrophils → neutrophil infiltration peaks at 24-48 hours → release of matrix metalloproteinases (MMP-2, MMP-9), reactive oxygen species, and myeloperoxidase → debris clearance but also bystander tissue damage
Complement activation via alternative pathway → C3 deposition on damaged cardiomyocytes → C3a and C5a release → enhanced neutrophil recruitment and mast cell degranulation → but C3-opsonized cells also signal "don't eat me yet" to protect salvageable myocardium
Resolution Phase (Days to Weeks):
Neutrophil apoptosis and efferocytosis by M2 macrophages → macrophage phenotype switch from M1 (pro-inflammatory) to M2 (pro-resolution) driven by phagocytosis of apoptotic neutrophils and IL-4 signaling → production of specialized pro-resolving mediators (resolvins, protectins, maresins) from omega-3 fatty acids via 15-LOX and 5-LOX pathways
M2 macrophages secrete TGF-β, VEGF, and platelet-derived growth factor → fibroblast activation and migration → collagen I and III deposition → scar maturation over 4-6 weeks → angiogenesis via VEGF-VEGFR2 signaling supporting granulation tissue
Reperfusion Injury:
If blood flow is restored (via PCI or thrombolysis), paradoxical damage occurs: sudden oxygen reintroduction → mitochondrial ROS burst → oxidative damage to lipids and proteins → calcium overload exacerbated → opening of mitochondrial permeability transition pore → cytochrome c release → apoptosis activation → additional cardiomyocyte death beyond the original ischemic zone
Emergency Context:
MI is the ultimate clinical demonstration of the double-edged nature of inflammation in cPNI. The inflammatory response is absolutely necessary for healing—complete suppression would prevent debris clearance and scar formation, leading to ventricular rupture. However, excessive or prolonged inflammation drives complications including heart failure (via adverse remodeling), arrhythmias (via electrical remodeling of the scar border zone), and recurrent ischemic events.
Evolutionary Mismatch:
The MUG mutation (loss of functional uricase) elevates uric acid, which in hunter-gatherer contexts may have provided antioxidant protection during rare famine-induced hypotension. In modern sedentary contexts with chronic hyperinsulinemia and hyperuricemia, the same mutation promotes endothelial dysfunction, atherosclerosis progression, and increased MI risk—a classic example of antagonistic pleiotropy.
Selfish Systems:
Post-MI, the selfish brain prioritizes its own glucose supply via stress-induced hyperglycemia (cortisol and catecholamine-driven hepatic gluconeogenesis), which paradoxically worsens cardiac outcomes by promoting oxidative stress and impairing insulin signaling in surviving myocardium. The selfish immune system may over-recruit inflammatory cells if chronic low-grade inflammation (metaflammation) has already primed circulating monocytes via trained immunity mechanisms.
Oral-Systemic Connection:
Periodontitis increases MI risk 2-3× via multiple mechanisms: systemic dissemination of Porphyromonas gingivalis and its virulence factors (gingipains), chronic elevation of CRP and IL-6 promoting endothelial dysfunction, molecular mimicry between oral bacteria and heat shock proteins on arterial endothelium, and platelet hyperreactivity induced by bacterial lipopolysaccharide. This makes oral hygiene a cardiovascular intervention, not just dental care.
Autonomic Dysfunction:
Low HRV pre-MI predicts higher arrhythmia risk and mortality post-MI. Three months of regular aerobic exercise (walking, cycling, swimming at 60-75% max heart rate, 30-45 minutes, 4-5×/week) improves HRV in both healthy subjects and post-MI patients by restoring autonomic balance—reducing sympathetic overdrive and enhancing parasympathetic vagal tone via regular activation of baroreceptor reflexes and increased brain-derived neurotrophic factor (BDNF) expression in cardiovascular control centers.
Clinical Biomarkers:
Intervention Timing:
Anti-inflammatory strategies must respect the biphasic nature of inflammation. NSAIDs during the acute phase (first 48 hours) impair scar formation and increase rupture risk. Resolution-phase support (omega-3 fatty acids at 2-4 g/day EPA+DHA starting at day 3-5) may enhance M2 macrophage function and SPM production, improving long-term remodeling. Chronic stress management and HRV training should begin in the subacute phase (weeks 2-4) to prevent autonomic dysfunction.